Psychedelics and Ibogaine “Pain Medications” at the Pharmacy Counter: Implications for Pharmacy Practice

Frank Breve,1 Frank J Berenato,2 Joseph V Pergolizzi Jr,3,4 Giustino Varrassi,5 Robert B Raffa3,61Clinical Pharmacy, Mid Atlantic PharmaTech Consultants, Ventnor City, NJ, USA; 2Compounding, Med Shoppe, Philadelphia, PA, USA; 3Research and Development, Enalare Therapeutics, Mullica Hill, NJ, USA; 4A...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Breve F, Berenato FJ, Pergolizzi JV Jr, Varrassi G, Raffa RB
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2026-07-01
Serie:	Journal of Pain Research
Soggetti:	psychedelics ibogaine FDA approval pharmacy practice REMS program pharmacogenomics
Accesso online:	https://www.dovepress.com/psychedelics-and-ibogaine-pain-medications-at-the-pharmacy-counter-imp-peer-reviewed-fulltext-article-JPR
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!